252 related articles for article (PubMed ID: 33307059)
1. Perinuclear anti-neutrophil cytoplasmic antibody in systemic lupus erythematosus indicates more severe condition.
Pan Y; He L
Clin Biochem; 2021 Mar; 89():38-43. PubMed ID: 33307059
[TBL] [Abstract][Full Text] [Related]
2. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies.
Pradhan VD; Badakere SS; Bichile LS; Almeida AF
J Assoc Physicians India; 2004 Jul; 52():533-7. PubMed ID: 15645975
[TBL] [Abstract][Full Text] [Related]
3. Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus.
Hanly JG; Su L; Farewell V; Fritzler MJ
J Immunol Methods; 2010 Jun; 358(1-2):75-80. PubMed ID: 20438730
[TBL] [Abstract][Full Text] [Related]
4. Anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus and lupus nephritis.
Pan HF; Fang XH; Wu GC; Li WX; Zhao XF; Li XP; Xu JH; Ye DQ
Inflammation; 2008 Aug; 31(4):260-5. PubMed ID: 18528749
[TBL] [Abstract][Full Text] [Related]
5. Serum antineutrophil cytoplasmic antibody positivity at the time of renal biopsy is associated with disease activity of lupus nephritis.
Zhang J; Lian R; Chen Y; Wan J
Ren Fail; 2024 Dec; 46(2):2357743. PubMed ID: 38847502
[TBL] [Abstract][Full Text] [Related]
6. Study on the correlation between anti-ribosomal P protein antibody and systemic lupus erythematosus.
Wang Y; Luo P; Guo T; Zou L; Shi J; Chen P
Medicine (Baltimore); 2020 May; 99(20):e20192. PubMed ID: 32443340
[TBL] [Abstract][Full Text] [Related]
7. Antineutrophil Cytoplasmic Antibody in Lupus Nephritis: Correlation with Clinicopathological Characteristics and Disease Activity.
Said D; Rashad NM; Abdelrahmanc NS; Dawaa GA
Curr Rheumatol Rev; 2021; 17(2):213-221. PubMed ID: 33292154
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus.
Pauzner R; Urowitz M; Gladman D; Gough J
J Rheumatol; 1994 Sep; 21(9):1670-3. PubMed ID: 7799347
[TBL] [Abstract][Full Text] [Related]
9. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance.
Schnabel A; Csernok E; Isenberg DA; Mrowka C; Gross WL
Arthritis Rheum; 1995 May; 38(5):633-7. PubMed ID: 7748219
[TBL] [Abstract][Full Text] [Related]
10. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus.
Spronk PE; Bootsma H; Horst G; Huitema MG; Limburg PC; Tervaert JW; Kallenberg CG
Br J Rheumatol; 1996 Jul; 35(7):625-31. PubMed ID: 8670594
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and outcomes of patients with antineutrophil cytoplasmic antibody-positive systemic lupus erythematosus.
Wang Y; Yu X; Xie X; Li H; Yang W; Liang Y; Lu W
Ren Fail; 2023 Dec; 45(1):2235431. PubMed ID: 37470370
[No Abstract] [Full Text] [Related]
12. Positive antineutrophil cytoplasmic antibody serology in patients with lupus nephritis is associated with distinct histopathologic features on renal biopsy.
Turner-Stokes T; Wilson HR; Morreale M; Nunes A; Cairns T; Cook HT; Pusey CD; Tarzi RM; Lightstone L
Kidney Int; 2017 Nov; 92(5):1223-1231. PubMed ID: 28750930
[TBL] [Abstract][Full Text] [Related]
13. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
Shang X; Ren L; Sun G; Yu T; Yao Y; Wang L; Liu F; Zhang L; He X; Liu M
Immun Inflamm Dis; 2021 Jun; 9(2):407-418. PubMed ID: 33470559
[TBL] [Abstract][Full Text] [Related]
14. Anti-neutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus.
Waldendorf M; Schneider M
Adv Exp Med Biol; 1993; 336():381-4. PubMed ID: 8296640
[TBL] [Abstract][Full Text] [Related]
15. [Expression and clinical significance of PD-L1 on CD14⁺ monocyte in the peripheral blood of patients with systemic lupus erythematosus].
Xie CH; Wang YY; Li ZJ; Tang J; Li BQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):429-32. PubMed ID: 22482418
[TBL] [Abstract][Full Text] [Related]
16. Antineutrophil cytoplasmic autoantibodies in patients with systemic lupus erythematosus recognize a novel 69 kDa target antigen of neutrophil granules.
Chen M; Zhao MH; Zhang YK; Wang HY
Nephrology (Carlton); 2005 Oct; 10(5):491-5. PubMed ID: 16221101
[TBL] [Abstract][Full Text] [Related]
17. Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus.
Sun J; Li X; Zhou H; Liu X; Jia J; Xie Q; Peng S; Sun X; Wang Q; Yi L
J Immunol Res; 2019; 2019():7430780. PubMed ID: 31049359
[TBL] [Abstract][Full Text] [Related]
18. Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study.
Manson JJ; Ma A; Rogers P; Mason LJ; Berden JH; van der Vlag J; D'Cruz DP; Isenberg DA; Rahman A
Arthritis Res Ther; 2009 Oct; 11(5):R154. PubMed ID: 19828047
[TBL] [Abstract][Full Text] [Related]
19. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
Pradhan VD; Patwardhan MM; Ghosh K
Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH
Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
